Psychopharmacology

Compound restores dopamine activity in a rat perimenopause model

In model rats, recordings averaged 1.201 active dopamine-producing cells per electrode path after the compound, versus 1.938 after an injection without it.

Paper by Kayla Lilly, Dishary Sharmin, James Minton Cook, Daniel J. Lodge, Stephanie M. Perez · The University of Texas at San Antonio Health Science Center
Figure 1. Expression of α5-GABAA receptors is not altered by either VCD treatment or PAM administration.
Open the figure at full size
Figure 1. Expression of α5-GABAA receptors is not altered by either VCD treatment or PAM administration.Expression of α5-GABAA receptors is not altered by either VCD treatment or PAM administration.Lilly et al.
Studied:
Experiments in 7 VCD-treated rats, against vehicle
What changed:
Dopamine neuron population activity was 1.201 ± 0.143 cells per track against 1.938 ± 0.148 cells per track with vehicle
The catch:
Only 7 rats per group in the electrophysiology recordings

Editor of record: Boris Djordjevic · AgingResearch.News

Follow @agingbrief

In an experiment in female Sprague Dawley rats around six months old, researchers tested MP-III-022 in a chemically induced model of perimenopause, the transition toward menopause. The model mimicked gradual loss of egg-containing structures in the ovaries and hormonal instability. The compound boosts receptors for a chemical that inhibits nerve cell activity.

Rats received a single injection of 10 milligrams per kilogram, or an injection without the compound, 20 minutes before brain recordings under anesthesia. Model rats had more spontaneously active dopamine-producing nerve cells along each recording electrode path than naturally cycling controls. MP-III-022 returned this measure to control levels. The reported comparisons included seven rats per group. The compound did not significantly change this measure in naturally cycling rats.

Why it matters

Psychiatric instability during the transition to menopause raises questions about alternatives to standard antipsychotics. The authors propose this receptor-targeting approach as one such alternative.

Caveats

The outcome was electrical activity in anesthetized rats, not psychiatric symptoms. This acute experiment did not establish symptom relief or improved tolerability in women.

Comments

Be the first to comment.